Belgium

Sales of analgesics are seeing robust growth in current value terms in 2023, continuing on from the steady performance seen in 2022. During 2022, sales of analgesics benefited from a sudden peak in cases of flu in the middle of the winter. This was…

Consumer health in Belgium continues to see steady growth in current value terms in 2023, albeit at a slightly slower pace than in the previous year. Among the most dynamic categories are analgesics, sleep aids (driven by high stress levels among the…

Sales of cough, cold and allergy (hay fever) remedies are seeing strong growth in current value terms in 2023. This is partly due to inflation-driven price increases (also the consequence of supply shortages in some cases) and an increase in cough,…

Sales of dermatologicals strongly rely on consumers visiting pharmacies (the dominant distribution channel) as Belgians rarely go first to these stores specifically to purchase such products. Instead these are generally secondary purchases alongside…

Dietary supplements continues to see steady current value growth in 2023, in line with the performance seen in 2022. However, since the beginning of 2022, there has been an explosion in the price of ingredients (often imported) and energy costs and…